alexa Involvement of Glycoprotein ib, αiibβ3 and Von Willebrand Factor in Platelet Production | OMICS International
ISSN: 2572-4916
Journal of Bone Research
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Involvement of Glycoprotein ib, αiibβ3 and Von Willebrand Factor in Platelet Production

Kenji Yokoyama*

Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan

Corresponding Author:
Kenji Yokoyama
Division of Hematology
Department of Medicine
Keio University School of Medicine 35 Shinano-machi
Shinjuku-ku, Tokyo 160-8582, Japan
Tel: +81-3-3353-1211 ext. 62385
Fax: +81-3-3353-3515
E-mail: [email protected]

Received Date: January 30, 2013; Accepted Date: February 16, 2013; Published Date: February 20, 2013

Citation: Yokoyama K (2013) Involvement of Glycoprotein ib, aiibß3 and Von Willebrand Factor in Platelet Production. J Bone Marrow Res 1:102. doi:10.4172/2329-8820.1000102

Copyright: © 2013 Yokoyama K. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Bone Research

Hematopoietic stem cells (HSCs) are differentiated into megakaryocytes (Mks), terminating in proplatelet formation and release of platelets [1-3]. Mks and platelets express specific receptors of extracellular proteins on their surface. Von Willebrand factor (VWF) is one of extracellular proteins that binds to platelets. VWF binds to glycoprotein Ib (GPIb) on the surface of platelets under high shear forces, subsequently platelet αIIbβ3 is activated and VWF and fibrinogen bind to activated αIIbβ3 resulting in platelet aggregation [4]. Thus interaction between VWF and platelet is important in hemostasis and patients with von Willebrand disease (VWD), those who are quantitative or qualitative deficient in VWF, have mild to moderate bleeding diathesis [5]. Mks also express both GPIb and αIIbβ3 [6], and VWF may bind to Mk GPIb and αIIbβ3.

GPIb is proved to be important in platelet production. Thrombocytopenia and giant platelets are found in Bernard-Soulier Syndrome (BSS), inherited bleeding disorders deficient in GPIb or carrying non-functional GPIb [7]. Impaired Mk synthesis and proplatelet formation was demonstrated in the animal models of BSS [8,9]. Involvement of GPIb in platelet production is also proved by the observations that anti GPIb antibodies from primary immune thrombocytopenia patients or quinidine-induced thrombocytopenia patients reduced Mk synthesis and proplatelet formation [10,11].

Compared to GPIb, αIIbβ3 seems to be less important in platelet production. Platelet count and size is normal in Glanzmann thrombasthenia (GT) characterized by severe quantitative or qualitative defects of αIIbβ3 [7]. However, recently patients with congenital macrothrombocytopenia having mutations in αIIbβ3 were reported. Constitutive activation of αIIbβ3-mediated outside-in signaling in Mks reduced proplatelet formation, resulting in macrhotrombocytopenia in these cases [12].

Proplatelet formation from Mk occurred after Mk plating on VWF [13]. Proplatelet formation and subsequent platelet release was accelerated by MK exposure to high shear forces, and it was abolished by anti VWF antibody [14]. Anti αIIbβ3 antibody, abciximab, also strongly reduced proplatelet formation and completely abolished platelet release under high shear forces. In addition, proplatelet formation under high shear was reduced on a VWF of type 2B VWD coating surface [14]. Type 2B VWD is a relatively rare form of VWD characterized by VWF with increased affinity to GPIb and mild to moderate thrombocytopenia [15]. These results suggest that shear forces promote interaction between VWF and MK GPIb, subsequently αIIbβ3 is activated, resulting in proplatelet formation and platelet release. Spontaneous binding of VWF of type 2B VWD to GPIb may impair platelet production under high shear forces. Giant platelets often appear in type 2B VWD and they may be a cause of impaired platelet production [16,17]. Reduced platelet production from type 2B VWD patients’ HSCs compared to that from healthy donors’ HSCs was also demonstrated [18]. Addition of exogenous native VWF increased platelet production from type 2B VWD patients’ HSCs [18]. These findings suggest that proper interaction between VWF and Mks plays important role in platelet production.

In summary, αIIbβ3 as well as GPIb may be involved in platelet production, however the mechanism how they affect the platelet production needs to be examined. VWF binding to these Mk receptors occurs under high shear forces in vitro, however considering platelet count and size is usually normal in patients with VWD except for type 2B VWD [5], the significance of interaction between VWF and Mks in vivo is still uncertain. Recent progress made it possible to produce platelets not only from HSCs but also from embryonic stem cells [19], induced pluripotent stem cells [20] and adipocyte precursor cells [21] in vitro, however yields of platelets are too low for clinical use. To reveal the roles of GPIb, αIIbβ3 and VWF in MK synthesis, proplatelet formation and platelet release may help to increase platelet production from these cells in vitro.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

  • International Conference on Emergency & Acute Care Medicine August 22-23, 2018 Tokyo, Japan
    August 22-23, 2018 Tokyo, Japan
  • 14th International Conference on Clinical Gastroenterology and Hepatology August 29-30, 2018 Toronto, Ontario, Canada
    August 29-30, 2018 Toronto, Canada
  • World Conference on Neurology and Neuromuscular Disorders September 13-14, 2018 Frankfurt, Germany
    September 13-14, 2018 Frankfurt, Germany
  • 9th International Conference on Clinical & Medical Case Reports September 17-18, 2018 | Amsterdam, Netherlands
    September 17-18, 2018 Amsterdam, Netherlands
  • World Congress on Fetal and Maternal Medicine October 15-17, 2018 Osaka, Japan
    October 15-17, 2018 Osaka, Japan
  • Complementary & Alternative Medicine October 17-18, 2018 Las Vegas | Nevada | USA
    October 17-18, 2018 Las Vegas, USA
  • 11th International Conference on Clinical and Medical Case Reports October 22-23, 2018 Turkey
    October 22-23, 2018 Istanbul, Turkey

Article Usage

  • Total views: 12091
  • [From(publication date):
    February-2013 - Jun 25, 2018]
  • Breakdown by view type
  • HTML page views : 8287
  • PDF downloads : 3804
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7